Sung-Min Ahn

Title: Innovations of Sung-Min Ahn in Cancer Treatment

Introduction

Sung-Min Ahn is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cancer treatment methods. His innovative work focuses on creating compounds that can effectively inhibit cancer cell proliferation.

Latest Patents

Sung-Min Ahn holds a patent for a compound titled "3-((8-((1H-pyrazol-4-yl)amino)imidazo[1,2-a]pyridin-3-yl)ethinyl)-n-phenylbenzamide derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of cancer." This invention relates to a derivative that can significantly inhibit the proliferation of cancer cells by targeting kinases, particularly Bcr-Abl kinase or Bcr-Abl (T315I) kinase. The derivative shows promise as an effective pharmaceutical composition for the prevention or treatment of cancer.

Career Highlights

Throughout his career, Sung-Min Ahn has worked with various organizations, including the Daegu-Gyeongbuk Medical Innovation Foundation and Immunoforge Co., Ltd. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative cancer therapies.

Collaborations

Sung-Min Ahn has collaborated with notable colleagues, including Doohyun Lee and Seungyeon Lee. These partnerships have played a crucial role in enhancing his research and expanding the impact of his inventions.

Conclusion

Sung-Min Ahn's work exemplifies the potential of innovative pharmaceutical research in combating cancer. His patented compound represents a significant advancement in cancer treatment, showcasing the importance of continued innovation in the medical field.